Investigational Site Number : 1560007

Tianjin 300020

0 studies enrolling now · 1 studies all time

What they study most

Plasma Cell Myeloma Recurrent

Studies at this site

• SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM — Running, not enrolling